DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slipped 1.35% to $21.19 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.27% to 19,054.84 and the Dow Jones Industrial Average rising 0.99% to 44,736.57.
Catalyst Pharmaceuticals Inc. closed $3.08 short of its 52-week high ($24.27), which the company achieved on November 8th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.39% to $155.78, Pfizer Inc. $(PFE)$ rose 2.03% to $26.17, and Abbott Laboratories $(ABT)$ rose 0.31% to $118.13.
Trading volume (865,543) remained 122,940 below its 50-day average volume of 988,483.
Data source: Dow Jones Market Data, FactSet. Data compiled November 25, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 25, 2024 17:23 ET (22:23 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments